Amphetamines and 3,4-methylendioxymetamphetamine (MDMA): evaluation of KIMS (kinetic interaction of microparticles in solution) assay at two cut-off levels
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 378892339 | ||
| 003 | CHVBK | ||
| 005 | 20180305123458.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 161128e20040510xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1515/CCLM.2004.092 |2 doi |
| 035 | |a (NATIONALLICENCE)gruyter-10.1515/CCLM.2004.092 | ||
| 245 | 0 | 0 | |a Amphetamines and 3,4-methylendioxymetamphetamine (MDMA): evaluation of KIMS (kinetic interaction of microparticles in solution) assay at two cut-off levels |h [Elektronische Daten] |c [Lucio Marchioro, Flavia Bassetto, Giuliano Dall'Olio, Luciano Tedeschi, Franca Castagna, Mario Plebani] |
| 520 | 3 | |a Two screening methods for the assay of amphetamines and their derivatives have been applied to the same analytical instrument for their evaluation. In addition to an assay at a cut-off of 1000 μg/l, a new specific reagent was evaluated for an ultra-sensitive assay of amphetamines and 3,4-methylendioxyme-tamphetamine with a cut-off of 300 μg/l. The assay confirmation was performed using high-performance liquid chromatography and gas chromatography/mass spectrometry techniques. The results were positive for both screening methods, confirming the efficacy of two simultaneous methods with different cut-off levels. | |
| 540 | |a Copyright © 2004 by Walter de Gruyter GmbH & Co. KG | ||
| 690 | 7 | |a Medical equipment & techniques |2 nationallicence | |
| 690 | 7 | |a Medical diagnosis |2 nationallicence | |
| 690 | 7 | |a Diseases & disorders |2 nationallicence | |
| 700 | 1 | |a Marchioro |D Lucio |4 aut | |
| 700 | 1 | |a Bassetto |D Flavia |4 aut | |
| 700 | 1 | |a Dall'Olio |D Giuliano |4 aut | |
| 700 | 1 | |a Tedeschi |D Luciano |4 aut | |
| 700 | 1 | |a Castagna |D Franca |4 aut | |
| 700 | 1 | |a Plebani |D Mario |4 aut | |
| 773 | 0 | |t Clinical Chemistry and Laboratory Medicine |d Walter de Gruyter |g 42/5(2004-05-10), 543-548 |x 1434-6621 |q 42:5<543 |1 2004 |2 42 |o cclm | |
| 856 | 4 | 0 | |u https://doi.org/10.1515/CCLM.2004.092 |q text/html |z Onlinezugriff via DOI |
| 908 | |D 1 |a research article |2 jats | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1515/CCLM.2004.092 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Marchioro |D Lucio |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Bassetto |D Flavia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Dall'Olio |D Giuliano |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Tedeschi |D Luciano |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Castagna |D Franca |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Plebani |D Mario |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Clinical Chemistry and Laboratory Medicine |d Walter de Gruyter |g 42/5(2004-05-10), 543-548 |x 1434-6621 |q 42:5<543 |1 2004 |2 42 |o cclm | ||
| 900 | 7 | |b CC0 |u http://creativecommons.org/publicdomain/zero/1.0 |2 nationallicence | |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-gruyter | ||